BNOX Bionomics Limited: Year-over-year earnings per share growth for the last twelve months

Official company branding of Bionomics Ltd. (BNOX)

The quarterly EPS growth history illustrates the dynamics of Bionomics Limited (BNOX), where the 0.00 level represents the current value. Business success is critically dependent on the results of neurodrug trials and external partners. The company has implemented "green chemistry" and strict bioethics in production. Stability is ensured by a strong staff of Australian scientists and the engagement of specialized regulatory experts.

Bionomics (BNOX) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 12/24/2024

Analytical breakdowns for Bionomics Limited

- share price and consensus valuation forecast:
Stock Quotes Bionomics|BNOX - Analyst Consensus Forecast
- company stock capitalization data:
Market Value Bionomics Limited|BNOX - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Bionomics|BNOX - Total Stockholders' Equity|Market Value to Book Value Ratio bionomics.com.au|BNOX - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Bionomics Limited|BNOX - Long-Term Liabilities to Capital|Short-Term Debt to Capital Bionomics Ltd.|BNOX - Company Total Indebtedness|Debt to Book Value Bionomics Ltd|BNOX - Long-Term Debt|Company Short-Term Debts Bionomics|Quick Ratio bionomics.com.au
- earnings and market multiples details:
BNOX - Net Financial Result|Expected Profit Bionomics Limited|BNOX - Market Cap to Earnings|Future Price to Earnings Bionomics Limited|BNOX - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bionomics Ltd|BNOX - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Bionomics|BNOX - Net earnings per share for the last 12 months|Quarterly EPS earnings growth bionomics.com.au|BNOX - Expected net earnings per share growth this year|Earnings growth forecast for next year Bionomics Limited
- sales volume and revenue indicators:
BNOX - Company Sales|Company Projected Revenue Bionomics Limited|BNOX - Price-to-Revenue Coefficient|Forward Price-to-Revenue Multiple Bionomics Limited
Fundamental company analysis:Bionomics Ltd., BNOX
Manufactured product of Bionomics Limited

The expansion of the Bionomics Limited (BNOX) drug portfolio for niche patient groups within the stable CNS segment directly impacts quarterly EPS dynamics. This indicator measures the growth rate of net income per share relative to operating expenses, allowing investors to assess the business's margin resilience against cost inflation and confirm the fundamental strength of the company's market value.

Analysis of competing companies

JAZZ (Jazz Pharmaceuticals PLC) - Year-over-year net earnings per share growth for the last 12 months|Cytokinetics Corp (CYTK) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months PTC Therapeutics, Inc.|SRRK: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Centessa Corp (CNTA)|Year-over-year earnings per share growth for the last twelve months DYN (Dyne Therapeutics Inc)|Year-over-year earnings per share growth for the last twelve months Edgewise Pharma EWTX|Rapport Corp - Year-over-year earnings per share growth for the last twelve months|ALMS - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Zevra Therapeutics|CTNM: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Larimar Pharma LRMR|Year-over-year net earnings per share growth for the last 12 months CAPR|Earnings per share growth in annualized terms for the last twelve months Entrada TRDA|Quarterly EPS earnings growth PTHS|Year-over-year net earnings per share growth for the last 12 months MediciNova MNOV|Year-over-year earnings per share growth for the last twelve months Serina Therapeutics SER|Year-over-year net earnings per share change for the last twelve months BioXcel Therapeutics Inc (BTAI)|PMN - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Apimeds Pharmaceuticals US APUS|AEON Biopharma (AEON) - Year-over-year earnings per share growth for the last twelve months|NLS Pharma - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months FSD Pharma|Quarterly EPS earnings growth Reata